Financial Ratios

CDR HEALTH CARE LTD.

NSE : NABSE : 523353ISIN CODE : INE369F01010Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 7.95 (5900)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 7.227.58
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)0.000.000.000.010.02
   CEPS(Rs)0.000.000.000.010.30
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)9.099.099.099.099.08
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-236.350.833.4341.84
   EBIT Margin(%)2.510.833.433.33
   Pre Tax Margin(%)1.420.593.132.98
   PAT Margin (%)1.420.593.132.98
   Cash Profit Margin (%)1.420.593.1341.49
Performance Ratios
   ROA(%)0.000.000.010.030.05
   ROE(%)0.010.010.030.130.23
   ROCE(%)0.000.010.010.050.09
   Asset Turnover(x)0.000.000.010.010.02
   Sales/Fixed Asset(x)0.000.000.010.010.01
   Working Capital/Sales(x)0.000.070.130.110.62
Efficiency Ratios
   Fixed Capital/Sales(x)948.70171.50193.6799.08
   Receivable days0.006634.307491.845029.89
   Inventory Days0.000.000.000.00
   Payable days0.000.000.000.00
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)383.6770.7679.9535.08
   EV/Core EBITDA(x)0.000.008571.312332.3883.84
   EV/EBIT(x)0.000.008571.312332.381054.86
   EV/CE(x)0.240.700.750.750.67
   M Cap / Sales0.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-100.00-81.9212.93-48.84-91.74
   Core EBITDA Growth(%)-58.78-45.08-72.80-95.81-6.33
   EBIT Growth(%)-58.78-45.08-72.80-47.27-27.46
   PAT Growth(%)-32.60-56.34-78.78-46.13102.95
   EPS Growth(%)-34.36-56.00-78.41-46.13102.95
Financial Stability Ratios
   Total Debt/Equity(x)0.002.082.152.151.69
   Current Ratio(x)1.171.171.751.751.17
   Quick Ratio(x)1.171.171.751.751.17
   Interest Cover(x)13.722.313.4911.699.53
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.